Journal of Medicinal Chemistry · 2023 · 14 citations · 16 references
Life SciencesBiochemistryOncologyMolecular OncologyPost-translational ModificationSignal TransductionProtein DegradationProtein TargetingProteolytic ProcessingRas Family OncogenesTargeted Cancer TherapyTargeted TherapyPost-translational Modification DetectionProtein Degradation SignalingProtein TargetsRas Post-translational ModificationRas SignalingRas-targeted TherapiesTargeted Protein Degradation
Protein degradation is emerging as a powerful strategy to modulate protein functions and alter cellular signaling pathways. Proteolysis-targeting chimeras (PROTACs) have been used to degrade a range of "undruggable" proteins in cells. Here, we present a type of chemically catalyzed PROTAC to induce rat sarcoma (RAS) degradation based on the chemistry of post-translational prenyl modification. Trimethylsilyl azide and Selectfluor were used to chemically tag the prenyl modification on Caax motif of RAS protein, and a sequential click reaction was applied using the propargyl pomalidomide probe to degrade the prenylated RAS in several cells. Thus, this approach was successfully applied to degrade RAS in multiple cancer cell lines including HeLa, HEK 293T, A549, MCF-7, and HT-29. This novel approach targeting RAS's post-translational prenyl modification to induce RAS degradation by employing the sequential azidation/fluorination and click reaction has been demonstrated efficiently and highly selectively, expanding PROTAC toolsets in the study of disease-relevant protein targets.
16
KRAS <sup>G12C</sup> Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong, Marwan Fakih, John H. Strickler et al. · New England Journal of Medicine · 2020 · 1.7K citations · Full text
Exploring Targeted Degradation Strategy for Oncogenic KRASG12C
Mei Zeng, Yuan Xiong, Nozhat Safaee et al. · Cell chemical biology · 2019 · 275 citations · Full text